By
Trending Posts
Can AstraZeneca’s $2.5B Beijing Bet Mark a New…
Key Highlights A $2.5B Strategic Move to Strengthen Global R&D Leadership AstraZeneca has announced a $2.5 billion strategic…
NVIDIA and GE HealthCare Join Forces to Accelerate…
Key Highlights: GTC, Santa Clara, CA — NVIDIA and GE HealthCare today announced a strategic collaboration to develop…
Pfizer and Data4Cure Collaborate to Advance AI-Driven Drug…
March 16, 2025 — Santa Clara, CAAt the 2025 Precision Medicine World Conference (PMWC), experts from Pfizer and…
AION Labs and BioMed X Launch Global 2025…
Backed by AstraZeneca, Merck, Pfizer, Teva, AWS, and top venture firms, the initiative seeks global innovators to build…
Stroke Care AI: How Are Medtronic and Brainomix…
Medtronic and Brainomix Join Forces to Deliver Faster, Smarter Stroke Care with AI-Powered Imaging February 27, 2025 –…
BullFrog AI and Eleison Pharmaceuticals Collaborate to Optimize…
Gaithersburg, Md – Feb 27 2025 BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a leading AI-driven drug development…
Incyte and Genesis Therapeutics Forge AI-Driven Partnership to…
BURLINGAME, California – Feb 20, 2025 Accelerating Innovation with AI-Powered Drug Design Incyte (Nasdaq: INCY) and Genesis Therapeutics…
AI-Powered Insilico Medicine Doses First Patient in Phase…
Cambridge, Mass. — Jan 22, 2025 Insilico Medicine, a biotechnology company leveraging generative artificial intelligence (AI) for drug…
Insilico Medicine’s AI Platform Unveils GBP2 and HCK…
InSilico Medicine — Jan 15, 2025AI-Driven Research Unveils New Therapeutic Approaches Researchers have leveraged artificial intelligence to discover…
Trending Posts
Latest Stories
How Caris Life Sciences’ $7.6B IPO the Breakout Moment for AI-Powered TechBio in Oncology and Beyond?
Key Highlights AI Meets Molecular Medicine: A New TechBio Contender EmergesCaris Life Sciences’ successful IPO…
Is Eli Lilly’s $1.3B Acquisition of Verve the Turning Point for CRISPR-Based Cardiovascular Therapies?
Key Highlights Strategic Bet on Early-Stage InnovationEli Lilly’s acquisition of Verve Therapeutics for up to…
Is HEALWELL AI’s Acquisition of BioPharma Canada’s Biggest AI-Driven CRO Leap Yet—and a Blueprint for Future Clinical Trials?
Key Highlights HEALWELL Targets AI-Driven Scale in CRO with $14.4M BioPharma AcquisitionHEALWELL AI Inc. (TSX:…
How Merck’s $3B MoonLake Acquisition the AI-Powered Bet That Will Reignite Late-Phase Biotech and Immune-Driven Precision Trials?
Key Highlights Merck Moves Decisively: A $3 Billion Signal to the Late-Stage Biotech MarketMerck has…
Gallery
